Collectively, these results suggest that targeted ablation of Fn14 exacerbates myopathy in mdx mice potentially due to impairment in muscle regeneration and overexpression of Fn14 in exogenous myoblasts enhances their engraftment in dystrophic muscle of mdx mice. Here, TNFRSF12A is linked to myopathy.